Search Results - "Pasricha, Sant‐Rayn"

Refine Results
  1. 1

    Iron deficiency by Pasricha, Sant-Rayn, Tye-Din, Jason, Muckenthaler, Martina U, Swinkels, Dorine W

    Published in The Lancet (British edition) (16-01-2021)
    “…Iron deficiency is one of the leading contributors to the global burden of disease, and particularly affects children, premenopausal women, and people in…”
    Get full text
    Journal Article
  2. 2

    Diagnosing anemia: Challenges selecting methods, addressing underlying causes, and implementing actions at the public health level by Garcia‐Casal, Maria Nieves, Dary, Omar, Jefferds, Maria Elena, Pasricha, SantRayn

    Published in Annals of the New York Academy of Sciences (01-06-2023)
    “…Accurate and affordable tools for diagnosing anemia and its main determinants are essential for understanding the magnitude and distribution of the problem and…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Iron deficiency, pregnancy, and neonatal development by Ataide, Ricardo, Fielding, Katherine, Pasricha, SantRayn, Bennett, Cavan

    “…Anemia affects 36% of pregnant women worldwide. Of those affected, around 40% is due to iron deficiency (ID). Iron is an essential micronutrient involved in…”
    Get full text
    Journal Article
  5. 5

    Control of iron deficiency anemia in low- and middle-income countries by Pasricha, Sant-Rayn, Drakesmith, Hal, Black, James, Hipgrave, David, Biggs, Beverley-Ann

    Published in Blood (04-04-2013)
    “…Despite worldwide economic and scientific development, more than a quarter of the world's population remains anemic, and about half of this burden is a result…”
    Get full text
    Journal Article
  6. 6

    The REVAMP trial: key questions remain – Authors' reply by Pasricha, Sant-Rayn, Moya, Ernest, Ataide, Ricardo, Mzembe, Glory, Harding, Rebecca, Phiri, Kamija

    Published in The Lancet (British edition) (06-01-2024)
    “…Use of the Ganzoni formula would generally have resulted in higher dosing (eg, up to 1500 mg, given over two doses).2 We recognise this concern but emphasise…”
    Get full text
    Journal Article
  7. 7

    Serum ferritin as an indicator of iron status: what do we need to know? by Daru, Jahnavi, Colman, Katherine, Stanworth, Simon J, De La Salle, Barbara, Wood, Erica M, Pasricha, Sant-Rayn

    Published in The American journal of clinical nutrition (01-12-2017)
    “…Determination of iron status in pregnancy and in young children is essential for both clinical and public health practice. Clinical diagnosis of iron…”
    Get full text
    Journal Article
  8. 8

    Daily iron supplementation for improving anaemia, iron status and health in menstruating women by Low, Michael Sze Yuan, Speedy, Joanna, Styles, Claire E, De-Regil, Luz Maria, Pasricha, Sant-Rayn

    Published in Cochrane database of systematic reviews (18-04-2016)
    “…Iron-deficiency anaemia is highly prevalent among non-pregnant women of reproductive age (menstruating women) worldwide, although the prevalence is highest in…”
    Get more information
    Journal Article
  9. 9

    Use and interpretation of hemoglobin concentrations for assessing anemia status in individuals and populations: results from a WHO technical meeting by Garcia‐Casal, Maria Nieves, Pasricha, SantRayn, Sharma, Andrea J., Peña‐Rosas, Juan Pablo

    Published in Annals of the New York Academy of Sciences (01-08-2019)
    “…Anemia is an important public health problem that negatively affects health of individuals and economic potential of populations. An accurate case definition…”
    Get full text
    Journal Article
  10. 10

    Erythroferrone inhibits the induction of hepcidin by BMP6 by Arezes, João, Foy, Niall, McHugh, Kirsty, Sawant, Anagha, Quinkert, Doris, Terraube, Virginie, Brinth, Alette, Tam, May, LaVallie, Edward R., Taylor, Stephen, Armitage, Andrew E., Pasricha, Sant-Rayn, Cunningham, Orla, Lambert, Matthew, Draper, Simon J., Jasuja, Reema, Drakesmith, Hal

    Published in Blood (04-10-2018)
    “…Decreased hepcidin mobilizes iron, which facilitates erythropoiesis, but excess iron is pathogenic in β-thalassemia. Erythropoietin (EPO) enhances…”
    Get full text
    Journal Article
  11. 11

    Reducing anaemia in low income countries: control of infection is essential by Pasricha, Sant-Rayn, Armitage, Andrew E, Prentice, Andrew M, Drakesmith, Hal

    Published in BMJ (Online) (01-08-2018)
    “…In settings with high infection burdens, iron interventions for anaemia may be neither safe nor effective. Strategies to tackle the global burden of anaemia…”
    Get full text
    Journal Article
  12. 12

    Iron restriction in sickle cell disease: When less is more by Castro, Oswaldo L., De Franceschi, Lucia, Ganz, Tomas, Kanter, Julie, Kato, Gregory J., Pasricha, SantRayn, Rivella, Stefano, Wood, John C.

    Published in American journal of hematology (01-07-2024)
    “…Primum non nocere! Can iron deficiency, an abnormality that causes anemia, benefit people with sickle cell disease (SCD) who already have an anemia? The…”
    Get full text
    Journal Article
  13. 13

    Measuring haemoglobin concentration to define anaemia: WHO guidelines by Pasricha, Sant-Rayn, Rogers, Lisa, Branca, Francesco, Garcia-Casal, Maria-Nieves

    Published in The Lancet (British edition) (18-05-2024)
    “…Anaemia is conventionally determined when the haemoglobin concentration falls below a defined threshold for age, sex, and physiological status.1 The accurate…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis by Pasricha, Sant-Rayn, Low, Michael, Thompson, Jane, Farrell, Ann, De-Regil, Luz-Maria

    Published in The Journal of nutrition (01-06-2014)
    “…Animal and human observational studies suggest that iron deficiency impairs physical exercise performance, but findings from randomized trials on the effects…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Hepatic iron is the major determinant of serum ferritin in NAFLD patients by Ryan, John D., Armitage, Andrew E., Cobbold, Jeremy F., Banerjee, Rajarshi, Borsani, Oscar, Dongiovanni, Paola, Neubauer, Stefan, Morovat, Reza, Wang, Lai Mun, Pasricha, SantRayn, Fargion, Silvia, Collier, Jane, Barnes, Eleanor, Drakesmith, Hal, Valenti, Luca, Pavlides, Michael

    Published in Liver international (01-01-2018)
    “…Background and Aims Elevated serum ferritin is common in NAFLD, and is associated with more advanced disease and increased mortality. Hyperferritinaemia in…”
    Get full text
    Journal Article
  18. 18

    Effect of daily iron supplementation on health in children aged 4–23 months: a systematic review and meta-analysis of randomised controlled trials by Pasricha, Sant-Rayn, Dr, Hayes, Emily, MBBS, Kalumba, Kongolo, FRACP, Biggs, Beverley-Ann, Prof

    Published in The Lancet global health (01-08-2013)
    “…Summary Background About 47% of preschool children worldwide are anaemic. Daily oral iron supplementation is a commonly recommended intervention for treatment…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Rivaroxaban in the treatment of TEK‐related venous malformation by Oo, Hnin P., Pasricha, SantRayn, Thompson, Bryony, Winship, Ingrid, Scardamaglia, Laura

    Published in Australasian journal of dermatology (01-08-2022)
    “…Low‐flow vascular malformations are rare congenital anomalies due to errors in vascular development and may be associated with known pathogenic genetic…”
    Get full text
    Journal Article